✨ Save up to 4 weeks on your antibody development with our new RocketAbs immunization platform!✨ Seize an Exclusive 30% Off Today! 🤩
Secured online payment available for peptide synthesis, gene synthesis, polyclonal antibody production and products
Antigen to bioproduction Hybridoma development Phage display services Antibody humanization Antibody affinity maturation by phage display Bispecific antibody development ADC development
Polyclonal antibody production Monoclonal antibody production Hybridoma development Phage display (scFv, VHH, Fab) immune and naïve libraries
Application guaranteed or no fee Instant online quotation!
Protein expression in 5 expression systems: E. coli, B. subtilis, yeast (P. pastoris& S. cerevisiae), Baculovirus insect cells, mammalian cells. High throughput protein expression Recombinant protein expression
Proprietary high performance cell lines
Peptide synthesis Peptide conjugation Peptide modification Peptide libraries
Instant online quotation!
Custom gene synthesis Gene subcloning Mutagenesis Gene library construction
Starting from 0.18€/bp Guaranteed service Fast delivery Instant online quotation!
Transient antibody production Stable cell line antibody production XtenCHOTM, unique productivity
IP free cell lines available Fermenters & bioreactors
Antibody affinity measurement (KD) Antibody sequencing Glycosylation profile analysis Endotoxin detection
Integrated solutions
Custom ELISA Kits ELISA sandwich development Competitive ELISA development
One stop solution from gene synthesis to kit delivery Guaranteed service
We collaborated with ProteoGenix for the development of monoclonal antibodies targeting a cell protein. The specificity, functionality and strong affinity of the antibodies developed convinced us to move forward with further humanization and bispecific development.
We appreciated the strong technical and scientific support of our contact which was decisive for the success of our project.
Dr. Christian Bronner PhD and principal scientist at CNRS
As a cofounder of ProteoGenix, I feel extremely proud and privileged to lead a team of spectacularly devoted and talented scientists committed in implementing our strong company values. Our contribution to the fascinating biopharma industry increases the proportion of monoclonal antibodies of any kind of format reaching the market and consequently improves human health.
The engineering of monoclonal antibodies into high potency IgGs, bi-specific antibodies, ScFvs or antibody-drug-conjugates (ADC) or any other format is an exciting task that we perform with passion every day. Our deep involvement in moving all biomolecules forward to the clinic in the best way reflects today’s incredible associated societal expectations. On behalf of ProteoGenix team, I look forward to serving you with sincere pleasure, carrying out your monoclonal antibody productions and pushing your leads to the clinic and eventually to the market.
ProteoGenix is a leading antibody production company founded in 2003. Our integrated solutions from gene to biotherapeutics& diagnostics make us the preferred partner of pharmaceutical & biotech companies for their custom assay development and therapeutic antibody discovery :
– Antibody generation including antigen design: hybridoma technology or phage display – Antibody engineering: humanization, affinity maturation, reformatting (bispecific antibodies, ADC…), subtype or isotype switching…
– Antibody production: recombinant monoclonal antibody production, stable cell line development… – Protein production: E. coli, B. subtilis, yeast, insect cells, mammalian cells – Custom peptide synthesis – Custom gene synthesis
Let’s partner and push your biotherapeutics to the clinic!
Adam, Senior Scientist in Cambridge
Your cart is currently empty.